论文部分内容阅读
肠道病毒性心脏病的病因、发病机制、诊断及治疗诸方面的众多基本问题多年来尚未解决,本文主要综述近5年来作者在分子水平上的研究成果,认为分子遗传及分子免疫学技术可能会导致突破性进展。
Many basic problems in etiology, pathogenesis, diagnosis and treatment of enteroviral heart disease have not been solved for many years. This article mainly summarizes the research achievements of the authors at the molecular level in the past 5 years and holds that the molecular genetic and molecular immunology technologies may be Will lead to a breakthrough.